shutterstock_1407371705_dcstockphotography

DCStockPhotography / Shutterstock.com

15 September 2022BiotechnologyStaff Writer

US company secures genetically modified rice ban against Chinese rival

Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

USITC to probe alleged engineered-rice theft by Chinese company

19 January 2021 The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

UPDATED: ITC blocks Chinese imports of rice-derived rHSA products after ALJ review

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice.

More on this story

USITC to probe alleged engineered-rice theft by Chinese company

19 January 2021 The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

UPDATED: ITC blocks Chinese imports of rice-derived rHSA products after ALJ review

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice.

More on this story

USITC to probe alleged engineered-rice theft by Chinese company

19 January 2021 The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

UPDATED: ITC blocks Chinese imports of rice-derived rHSA products after ALJ review

20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice.

More features

President Trump 2.0: Five major areas to watch

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug